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In a recent report, our group presented clinical research data supporting the role of mannose-binding lectin
(MBL) deficiency in susceptibility to meningococcal disease (W. A. Bax, O. J. J. Cluysenaer, A. K. M. Bartelink,
P. C. Aerts, R. A. B. Ezekowitz, and H. van Dijk, Lancet 354:1094-1095, 1999). This association was reported
earlier by Hibberd et al. (M. L. Hibberd, M. Sumiya, J. A. Summerfield, R. Booy, M. Levin, and the
Meningococcal Research Group, Lancet 353:1049-1053, 1999) but was not based on family data. Our study
included three members of one family who had acquired meningococcal meningitis in early adulthood. The
objective of the present study was to investigate whether the genotypes of the MBL gene in this family, analyzed
by PCR, correlate with MBL concentrations. We found that genotype variants in the MBL gene and promoter
region match the low functional MBL levels (<0.25 g of equivalents/ml) in the sera of the three patients in
this family and that a significant correlation between genotype MBL deficiency and meningococcal disease
existed.
Three point mutations in the mannose-binding lectin (MBL)
gene are each known to reduce serum lectin levels and con-
tribute to a deficiency of the MBL protein. In 1995, Madsen et
al. (8) showed that additional mutations in the promoter re-
gion of the MBL gene play an additional role in reduced MBL
levels. That paper reported the frequencies of the promoter
haplotypes which regulate the expression of the peptide in
populations of pure Eskimos, Caucasians, and black Africans
and discussed their putative role.
This short report presents the genotypic data (gene and
promoter variants) from a large family with three members
who had acquired meningococcal meningitis in early childhood
and the correlation between these genotypes and MBL con-
centrations in the sera (described in a recent report [1]).
EDTA blood samples were collected from all known mem-
bers of the family, followed by genomic DNA isolation using a
commercially available isolation kit according to the manufac-
turer’s instructions (QIAamp DNA Blood Mini kit; QIAGEN,
Hilden, Germany). Genomic PCRs were performed in 50-l
volumes containing primers specific for the alleles described by
Madsen et al. (8) in the exon 1 region (wild-type A and the
variant alleles B, C, and D). The same was done for the variant
alleles in the promoter region of the MBL gene: H and L, X
and Y. DNA was amplified as described by Madsen et al. (7, 8),
using general PCR and site-directed mutagenesis PCR for
types A, B, C, and D and PCR with sequence-specific priming
for types H/L and X/Y. Wild-type (type A) and B, C, and D
alleles were distinguished by restriction enzyme digestions of
the PCR products (7, 8). The cis/trans locations of the pro-
moter variants H/L and X/Y relative to the structural variants
A, B, C, and D were determined as well. Madsen and col-
leagues stressed in their report (8) that all of their attempts to
use the PCR with sequence-specific priming technique in typ-
ing the H allele had failed. We, in contrast, succeeded by using
the primer 5-TTA-CCC-AGG-CAA-GCC-TGT-G-3 and 40
cycles of 30 s at 94°C, 60 s at 68°C, and 60 s at 72°C (see Fig.
1).
MBL concentrations in serum samples of the family mem-
bers were measured using a functional MBL assay (6) with
purified wild-type MBL as a reference protein (a kind gift from
P. Garred, Statens Serum Institute, Copenhagen, Denmark) as
previously described (1).
Three variants of polymorphism in the coding region of the
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FIG. 1. PCR to discriminate between the H and L alleles in the
promoter region of the MBL gene. Lanes 1 to 5, PCR for the L allele;
lanes 6 to 10, PCR for the H allele. Samples shown are from an
individual (ind.) who expressed both the L and H alleles (D, lanes 4
and 9) and from individuals who expressed only the L allele (B, lanes
2 and 7; C, lanes 3 and 8) or only the H allele (A, lanes 1 and 6). Lanes
5 and 10 are negative controls. MM, size marker DNA.
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MBL gene were found (A [wild type], B, and D), which led to
the combinations A/A, A/B, A/D, B/D, B/B, and D/D. This
family study confirms the pattern predicted by Madsen et al.
(8) in their model of the evolution of the MBL gene: the X
allele was found only in combination with the A variant and the
L allele, while the D variant was exclusively found in combi-
nation with HY and the B variant was found only with LY (see
Fig. 2). In addition, the HY, LY, and LX haplotypes correlated
with different levels of serum MBL: HY with high, LY with
intermediate, and LX with low levels. It is remarkable that
variants in the promoter region (LX associated with wild-type
A) correlate with relative low levels of functional MBL in
heterozygotes for MBL codon variants.
Results of clinical studies have shown associations between
MBL mutations and susceptibility to infection in patients with
systemic lupus erythematosus (3), increased episodes of acute
respiratory infection (5), and risk of invasive pneumococcal
disease (10) and meningococcal disease (4). MBL deficiency is
also associated with severe atherosclerosis (9) and risk of mis-
carriage (2).
In conclusion, earlier (Lancet) data (1) and our group’s
recent genotypic findings, mentioned here, indicate that MBL
genotypes match their corresponding phenotypes, suggesting
that MBL phenotyping (6) can be used to provisionally identify
MBL-deficient subjects in a human population.
This study was supported by a grant from the “Stichting Bijstand” of
the Meander Medical Centre, Amersfoort, The Netherlands.
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FIG. 2. Family pedigree of the three patients with meningitis (shaded boxes). Values correspond to MBL concentrations in serum expressed
in microgram equivalents/milliliter. Genotypes A (wild type), B, C, and D in the coding region of MBL are shown, and the alleles in the promoter
region are given in parentheses.
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